-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Mid-Morning market update: Markets mixed; Kroger tops Q2 views
Mid-Morning market update: Markets mixed; Kroger tops Q2 views
Following the market opening Friday, the Dow traded down 0.15% to 34,827.04 while the NASDAQ rose 0.32% to 15,296.61. The S&P also rose, gaining 0.03% to 4,494.53.
Leading and Lagging Sectors
Consumer discretionary shares gained 0.6% on Friday. Meanwhile, top gainers in the sector included $Greenlane Holdings Inc(GNLN.US)$, up 13% and $Onion Global(OG.US)$ up 8%.
In trading on Friday, real estate shares fell by 0.9%.
Top Headline
$The Kroger(KR.US)$ reported better-than-expected results for its second quarter on Friday.
Kroger reported quarterly earnings of $0.80 per share, beating analysts' estimates of $0.64 per share. The company's quarterly sales came in at $31.68 billion, versus expectations of $30.68 billion.
Kroger said it sees FY21 earnings of $3.25 to $3.35 per share, versus analysts' estimates of $3.06 per share.
Equities Trading UP
$IVERIC bio Inc(ISEE.US)$ shares shot up 65% to $14.32 after $Apellis Pharmaceuticals Inc(APLS.US)$ reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22.
Shares of $Echo Global Logistics Inc(ECHO.US)$ got a boost, shooting 54% to $48.17 after the company agreed to be acquired by private equity firm The Jordan Company.
$Endo International(ENDP.US)$ shares were also up, gaining 54% to $3.23 after the company said it has settled three consolidated opioid cases pending in Suffolk County Supreme Court in the State of New York. As a result of the settlement, Endo has been severed from the trial.
Equities Trading DOWN
Apellis Pharmaceuticals Inc. shares tumbled 46% to $30.01 after the company reported mixed top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan in 1,258 adults with geographic atrophy secondary to age-related macular degeneration. The OAKS study met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% and 16%, respectively, compared to pooled sham at 12 months. However the DERBY study did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% and 11%, with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.
Shares of $KAVL BRND INOVTN(KAVL.US)$ were down 41% to $6.00 after climbing over 20% on Thursday.
$Mersana Therapeutics Inc(MRSN.US)$ was down, falling 36% to $9.06.
Commodities
In commodity news, oil traded up 2% to $69.48, while gold traded down 0.2% to $1,795.90.
Silver traded down 0.1% Friday to $24.145 while copper rose 3.5% to $4.4355.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.1%, the Spanish Ibex Index fell 1.3% and the German DAX 30 gained 0.1%. Meanwhile, the London's FTSE 100 rose 0.1%, French CAC 40 slipped 0.1% and Italy's FTSE MIB slipped 0.6%.
French industrial production increased 0.3% in July, while Italy's industrial production rose 0.8% from a month ago in July. Annual consumer price inflation rate in Germany was confirmed at 3.9% in August.
The UK GDP expanded by 3.6% during the three months to July, while industrial production rose 1.2% in July. The UK trade deficit increased to GBP 3.1 billion in July from GBP 2.5 billion in the earlier month. Imports to the UK rose 1.1%, while exports slipped 0.1% from the previous month in July.
Economics
Producer prices for final demand rose 0.7% in August.
US wholesale inventories rose 0.6% month-over-month to $722 billion in July.
The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.
Following the market opening Friday, the Dow traded down 0.15% to 34,827.04 while the NASDAQ rose 0.32% to 15,296.61. The S&P also rose, gaining 0.03% to 4,494.53.
上週五開盤後,道瓊斯工業平均指數下跌0.15%,至34,827.04點;納斯達克指數上漲0.32%,至15,296.61點。標準普爾500指數也上漲0.03%,至4,494.53點。
Leading and Lagging Sectors
領先和落後行業
Consumer discretionary shares gained 0.6% on Friday. Meanwhile, top gainers in the sector included $Greenlane Holdings Inc(GNLN.US)$, up 13% and $Onion Global(OG.US)$ up 8%.
非必需消費品類股週五上漲0.6%。與此同時,漲幅最大的是扇區包括在內$Greenlane Holdings Inc.(GNLN.US)$,上漲13%,$Onion Global(OG.US)$上漲8%。
In trading on Friday, real estate shares fell by 0.9%.
在週五的交易中,房地產類股下跌了0.9%。
Top Headline
頭條新聞
$The Kroger(KR.US)$ reported better-than-expected results for its second quarter on Friday.
$克羅格(KR.US)$上週五,該公司公佈了好於預期的第二季度業績。
Kroger reported quarterly earnings of $0.80 per share, beating analysts' estimates of $0.64 per share. The company's quarterly sales came in at $31.68 billion, versus expectations of $30.68 billion.
克羅格公佈的季度收益為每股0.80美元,超過分析師預期的每股0.64美元。該公司季度銷售額為316.8億美元,高於預期的306.8億美元。
Kroger said it sees FY21 earnings of $3.25 to $3.35 per share, versus analysts' estimates of $3.06 per share.
克羅格表示,預計2011財年每股收益為3.25美元至3.35美元,高於分析師預期的3.06美元。
Equities Trading UP
股票交易價格上漲
$IVERIC bio Inc(ISEE.US)$ shares shot up 65% to $14.32 after $Apellis Pharmaceuticals Inc(APLS.US)$ reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22.
$IVERIC BIO Inc.(ISEE.US)$股價飆升65%,至14.32美元,此前$Apellis PharmPharmticals Inc.(APLS.US)$報告了其在地理萎縮方面的第三階段德比和橡樹研究結果。Apellis的競爭對手IVERIC Bio也在開發一種治療地理萎縮的產品,名為Zimura。Stifel以買入評級啟動了IVERIC Bio的報道,並宣佈目標價為22美元。
Shares of $Echo Global Logistics Inc(ECHO.US)$ got a boost, shooting 54% to $48.17 after the company agreed to be acquired by private equity firm The Jordan Company.
的股份$Echo全球物流公司(ECHO.US)$在該公司同意被私募股權公司The Jordan Company收購後,該公司股價上漲54%,至48.17美元。
$Endo International(ENDP.US)$ shares were also up, gaining 54% to $3.23 after the company said it has settled three consolidated opioid cases pending in Suffolk County Supreme Court in the State of New York. As a result of the settlement, Endo has been severed from the trial.
$遠藤國際(ENDP.US)$股價也上漲了54%,至3.23美元,此前該公司表示,已就紐約州薩福克縣最高法院懸而未決的三起合併阿片類藥物案件達成和解。作為和解的結果,遠藤已被切斷與審判的聯繫。
Equities Trading DOWN
股票交易價格下跌
Apellis Pharmaceuticals Inc. shares tumbled 46% to $30.01 after the company reported mixed top-line results from the Phase 3 DERBY and OAKS studies evaluating intravitreal pegcetacoplan in 1,258 adults with geographic atrophy secondary to age-related macular degeneration. The OAKS study met the primary endpoint for both monthly and every-other-month treatment with pegcetacoplan, demonstrating a significant reduction in GA lesion growth of 22% and 16%, respectively, compared to pooled sham at 12 months. However the DERBY study did not meet the primary endpoint of GA lesion growth, showing a reduction of 12% and 11%, with monthly and every-other-month treatment, respectively, compared to pooled sham at 12 months.
Apellis PharmPharmticals Inc.股價暴跌46%,至30.01美元,此前該公司公佈了3期德比和橡樹研究的喜憂參半的結果,該研究評估了1,258名繼發於老年性黃斑變性的地理萎縮成年人的玻璃體內注射聚乙二醇胺計劃。Oaks的研究達到了每月和每隔一個月使用pegcetaco計劃治療的主要終點,顯示出與12個月的合併Sham相比,GA皮損的增長分別顯著減少了22%和16%。然而,德比研究沒有達到GA病變增長的主要終點,與12個月的聯合Sham相比,每月和每隔一個月的治療分別減少了12%和11%。
Shares of $KAVL BRND INOVTN(KAVL.US)$ were down 41% to $6.00 after climbing over 20% on Thursday.
的股份$KAVL BRND INOVTN(KAVL.US)$在週四攀升逾20%後,股價下跌41%,至6.00美元。
$Mersana Therapeutics Inc(MRSN.US)$ was down, falling 36% to $9.06.
$Mersana治療公司(MRSN.US)$下跌36%,至9.06美元。
Commodities
商品
In commodity news, oil traded up 2% to $69.48, while gold traded down 0.2% to $1,795.90.
大宗商品新聞方面,油價上漲2%,至每桶69.48美元,而黃金下跌0.2%,至每桶1,795.90美元。
Silver traded down 0.1% Friday to $24.145 while copper rose 3.5% to $4.4355.
上週五,銀價下跌0.1%,至每盎司24.145美元,銅價上漲3.5%,至每盎司4.4355美元。
Euro zone
歐元區
European shares were mostly lower today. The eurozone's STOXX 600 slipped 0.1%, the Spanish Ibex Index fell 1.3% and the German DAX 30 gained 0.1%. Meanwhile, the London's FTSE 100 rose 0.1%, French CAC 40 slipped 0.1% and Italy's FTSE MIB slipped 0.6%.
歐洲股市今天大多走低。歐元區STOXX 600指數下跌0.1%,西班牙IBEX指數下跌1.3%,德國DAX 30指數上漲0.1%。與此同時,倫敦富時100指數上漲0.1%,法國CAC 40指數下跌0.1%,意大利富時MIB指數下跌0.6%。
French industrial production increased 0.3% in July, while Italy's industrial production rose 0.8% from a month ago in July. Annual consumer price inflation rate in Germany was confirmed at 3.9% in August.
法國7月工業生產增長0.3%,意大利7月工業生產較前月增長0.8%。德國8月份的年度消費者價格通脹率被確認為3.9%。
The UK GDP expanded by 3.6% during the three months to July, while industrial production rose 1.2% in July. The UK trade deficit increased to GBP 3.1 billion in July from GBP 2.5 billion in the earlier month. Imports to the UK rose 1.1%, while exports slipped 0.1% from the previous month in July.
在截至7月份的三個月裏,英國GDP增長了3.6%,而7月份工業生產增長了1.2%。英國7月份的貿易逆差從前一個月的25億英鎊增加到31億英鎊。7月份,英國進口增長1.1%,出口環比下滑0.1%。
Economics
經濟學
Producer prices for final demand rose 0.7% in August.
8月份最終需求的生產者價格上漲了0.7%。
US wholesale inventories rose 0.6% month-over-month to $722 billion in July.
美國7月批發庫存環比增長0.6%,至7,220億美元。
The Baker Hughes North American rig count report for the latest week is scheduled for release at 1:00 p.m. ET.
貝克休斯最近一週的北美鑽機數量報告定於下午1點發布。Et.
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧